
Dash Bio automates clinical bioanalysis to speed drug development and improve assay quality. It combines AI, laboratory robotics, and integrated software to run highly automated, GLP‑compliant labs…

Dash Bio automates clinical bioanalysis to speed drug development and improve assay quality. It combines AI, laboratory robotics, and integrated software to run highly automated, GLP‑compliant labs…
Founded: 2024
Headquarters: Boston area (Waltham/Newton/Boston listed addresses)
What they do: Tech-first bioanalysis CRO combining AI, robotics, and software to run automated GLP-capable labs
Core services: Automated bioanalytical assays (ELISA, MSD, qPCR, ddPCR, targeted LC-MS) and integrated data pipelines
Total disclosed funding: $17.5M (seed rounds)
Bioanalysis and bioanalytical data workflows for biopharma and research laboratories.
2024
Biotechnology Research
$6.5M
Initial seed financing announced Oct 24, 2024.
$11M
Additional seed financing announced Jul 23, 2025 bringing total disclosed funding to $17.5M.
“The Aligned Fund, Freestyle Capital, Swift Ventures, LifeX Ventures, Drive Capital, Cybernetix Ventures, and other private investors participated across seed rounds”
| Company |
|---|
Our Mission:
Dash accelerates drug development. By fusing advanced automation-native lab workflows and integrated software into a unified platform, we provide the biopharma industry with the high-velocity, high-quality, data-driven development solutions required to get life-saving therapies to patients faster. Dash seeks to continuously improve industry KPIs and materially reduce the time and cost to bring a drug to market.
Company Summary:
We are building the infrastructure for modern drug development. We are moving beyond the manual, fragmented processes of traditional service providers by taking a technology-first approach to bioanalysis. Our platform is tech-enabled, automated, and GLP-compliant with the goal to industrialize the scientific workflows that act as bottlenecks in the industry. We deliver next-generation preclinical and clinical bioanalysis results with unprecedented speed and precision.
We are a team of builders operating at the intersection of biology, hardware, and code. This is an environment for scientists and engineers who are tired of the status quo and are ready to apply their skills to solve hard problems at scale. We don't just run assays, we architect the systems that will define the future of drug development.
We are a place where employees are stretched to do the best work of their career. We are looking for engineers, scientists, and biotechnicians who want to make an impact on the world and leverage their skills in an innovative way.
Job Description:
We are seeking an Associate Software Engineer (Full Stack) to support the development and maintenance of software solutions for lab automation and bioanalysis workflows. This role is on-site in Waltham, MA, offering a unique opportunity for a recent graduate or early-career engineer to work at the intersection of software and physical lab systems. You will work under the guidance of senior engineers to build tools that directly impact drug development.
Key Responsibilities:
Qualifications:
What We Offer:
Salary Range: $60,000 – $85,000 per year
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week